Commentary

You have free access to this content

Can a gene-expression classifier with high negative predictive value solve the indeterminate thyroid fine-needle aspiration dilemma?

  1. William C. Faquin MD, PhD†,*

Article first published online: 30 JAN 2013

DOI: 10.1002/cncy.21277

Issue

Cancer Cytopathology

Cancer Cytopathology

Volume 121, Issue 3, pages 116–119, March 2013

Additional Information

How to Cite

Faquin, W. C. (2013), Can a gene-expression classifier with high negative predictive value solve the indeterminate thyroid fine-needle aspiration dilemma?. Cancer Cytopathology, 121: 116–119. doi: 10.1002/cncy.21277

Author Information

  1. Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts

  1. †

    Fax: (617) 573-3389

*Department of Pathology, Warren 219, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114;

  1. †

    Fax: (617) 573-3389

Publication History

  1. Issue published online: 13 MAR 2013
  2. Article first published online: 30 JAN 2013
  3. Manuscript Revised: 7 DEC 2012
  4. Manuscript Received: 17 OCT 2012

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (88K)

Abstract

The recent study by Alexander et al validates the effectiveness of the Afirma test, and suggests a potential ancillary role for this unique test when appropriately applied in the evaluation of thyroid nodules classified by fine-needle aspiration as indeterminate. Cancer (Cancer Cytopathol) 2013. © 2013 American Cancer Society

View Full Article (HTML) Get PDF (88K)